Ifosfamide plasma clearance in relation to polymorphic debrisoquine oxidation
- PMID: 3168145
- DOI: 10.1007/BF00254239
Ifosfamide plasma clearance in relation to polymorphic debrisoquine oxidation
Abstract
Ifosfamide (IF) pharmacokinetics and the plasma (NBP)-alkylating activity were determined in 33 patients with different tumours after the administration of IF as single-agent chemotherapy. All subjects had been phenotyped for debrisoquine oxidation. There is a lack of correlation between the debrisoquine metabolic ratio (DMR) and either the total plasma clearance of IF (CLIF) or the AUC of the plasma NBP-alkylating activity.
Similar articles
-
Evidence for the polymorphic oxidation of debrisoquine in the Thai population.Br J Clin Pharmacol. 1990 Feb;29(2):244-7. doi: 10.1111/j.1365-2125.1990.tb03627.x. Br J Clin Pharmacol. 1990. PMID: 2306417 Free PMC article.
-
Polymorphic oxidation of debrisoquine in bladder cancer.Ann Med. 1990 Jun;22(3):157-60. doi: 10.3109/07853899009147261. Ann Med. 1990. PMID: 2393550
-
Polymorphic oxidation of sparteine and debrisoquine: related pharmacogenetic entities.Clin Pharmacol Ther. 1982 Feb;31(2):184-6. doi: 10.1038/clpt.1982.29. Clin Pharmacol Ther. 1982. PMID: 7056024
-
Polymorphic oxidation of debrisoquine and sparteine.Prog Clin Biol Res. 1986;214:157-67. Prog Clin Biol Res. 1986. PMID: 3523506 Review. No abstract available.
-
The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.Clin Pharmacokinet. 1986 Jan-Feb;11(1):1-17. doi: 10.2165/00003088-198611010-00001. Clin Pharmacokinet. 1986. PMID: 2868819 Review.
Cited by
-
3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.Drug Metab Dispos. 2006 Sep;34(9):1563-74. doi: 10.1124/dmd.105.008920. Epub 2006 Jun 16. Drug Metab Dispos. 2006. PMID: 16782768 Free PMC article. Clinical Trial.
-
Ifosfamide clinical pharmacokinetics.Clin Pharmacokinet. 1994 Jun;26(6):439-56. doi: 10.2165/00003088-199426060-00003. Clin Pharmacokinet. 1994. PMID: 8070218 Review.
-
Ifosfamide pharmacokinetics.Invest New Drugs. 1991 Nov;9(4):305-11. doi: 10.1007/BF00183570. Invest New Drugs. 1991. PMID: 1804803 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous